European Archives - Page 153 of 1369 - European Medical Journal

Evidence on VNS in the Modern DRE Treatment Landscape

Epilepsy affects around 50 million people worldwide. Approximately 30% of them experience drug-resistant epilepsy (DRE), which…

Patient-Reported Outcome Measures, 1 Year After COVID-19

Learn more about the long-term health effects persisting one year after COVID-19 infection, including fatigue, breathlessness…

A collection of illustrated lab equipment

Novo Nordisk taps Replicate’s srRNA platform for obesity

Novo Nordisk partners with Replicate Bioscience in a $550M srRNA deal to develop new therapies for obesity, diabetes and cardiometabolic diseases.

CABANA Trial: Catheter Ablation Benefits Selected Patients with Atrial Fibrillation

Find out who benefits most from catheter ablation for atrial fibrillation according to new research. Keep reading to learn more.

Ten-Year Follow-Up Shows Survival Gains in Prostate Cancer

Discover a study showing lasting survival gains from treatment intensification in prostate cancer.

Vaccination Protects from Asthma and Rhinitis Linked to COVID-19

COVID-19 infection raises risks of asthma, rhinitis, and sinusitis, while vaccination reduces respiratory type-2 inflammatory disease incidence.

18F-FES PET/CT Accurately Detects Lymph Node Spread in Lobular Breast Cancer

Learn how a new scan shows promise for staging invasive lobular breast cancer with 100% specificity in small feasibility study.

New AI Pipeline Speeds Cancer Tissue Analysis And Biomarker Discovery

Explore how new AI technology speeds up whole-slide cancer analysis for better research and treatment strategies. Keep reading.

Psychological Recovery and Quality of Life in Patients with Breast Cancer

A four-year prospective study finds that breast cancer survivors experience improvements in depression, anxiety, pain, and quality of life after treatment, though women who underwent mastectomy reported higher long-term anxiety than those who had breast-conserving surgery.

Erratum: Luteinising Hormone-Releasing Hormone Antagonists in Prostate Cancer: Myths and Facts